Sandoz Pledges Price Stability Amid Coronavirus

CEO Richard Saynor Discusses Chinese Supply-Chain Pressures

Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.

Covid-19
Sandoz will ensure stable pricing for a basket of coronavirus-related essential drugs • Source: Shutterstock

Sandoz will maintain stable pricing for coronavirus-related essential medicines that it markets, CEO Richard Saynor has pledged, amid ongoing concerns over the potential short-term and longer-term impacts of the outbreak on the supply chain.

As “the number one provider of off-patent antibiotic medicines worldwide,” Sandoz said it was “making a public commitment to ensure stable pricing for a basket of essential medicines the company markets, which may help to treat coronavirus patients, amid growing

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Drug Pricing

More from Policy & Regulation